Trial Profile
A study on the effect of memantine for psychological symptoms and cerebral blood flow of patients with Alzheimer's disease.
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 25 Nov 2014
Price :
$35
*
At a glance
- Drugs Memantine (Primary) ; Cholinesterase inhibitors
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 28 May 2013 New trial record